NDC 81927-106 – Tepylute

Thiotepa 10 mg/mL · Injection · Intravenous

Human Prescription Drug

Product NDC81927-106

Product details

Brand name
Tepylute
Generic name
thiotepa
Labeler
Shorla Oncology Inc.
Dosage form
Injection
Route
Intravenous
Marketing category
NDA · NDA216984
Marketed since
March 31, 2025
Marketing end
September 30, 2026
Pharmacologic class
Alkylating Drug

Active ingredients

Package NDC codes (1)

Package NDCDescriptionSince
81927-106-011 VIAL, MULTI-DOSE in 1 CARTON (81927-106-01) / 10 mL in 1 VIAL, MULTI-DOSEMar 31, 2025

Other Tepylute products